JYJohn Erikson L. Yap

John Erikson L. Yap

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John Erikson L. Yap has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pharmacy Intervention Matters: Improving the Quality of Care of Helicobacter pylori Treatment

    by Omar Soudan, Rand Soudan, Tara Koehler, Nimisha Vasandani, Apryl Cronley, Pooja J. Mude, Ahmad Alkaddour, Carlos Palacio, John Erikson L. Yap, Kenneth J. Vega

    Objectives: Helicobacter pylori (HP) infection has an estimated prevalence of ~4.4 billion individuals worldwide. Clinical manifestations range from asymptomatic to mucosa-associated lymphoid tissue lymphoma. Effective eradication depends on both appropriate treatment selection and patient adherence. The study aims were compare HP eradication rates, antibiotic regimen selection and confirmation testing between patients managed by a clinical pharmacist versus standard care. Methods: A retrospective review of adults diagnosed and treated for HP was performed between March 2019 and November 2021. Patients were divided into two sequential cohorts: a pre-pharmacy group receiving standard care, and a pharmacist intervention group in which a clinical pharmacist managed treatment and documented HP eradication. Data analyzed included multiple demographic and clinical factors. Eradication was assessed by intention-to-treat (ITT) and per-protocol analysis with proportions compared using chi-square or Fisher’s Exact Test for low cell counts. Results: A total of 134 patients were diagnosed and treated for HP during the study period: 38 in the pre-pharmacy group and 96 in the pharmacist intervention group. In ITT analysis, successful eradication did not differ significantly between groups. Per-protocol analysis revealed significantly higher eradication in the pharmacist group. Antibiotic regimens overall differed between the cohorts with less use of clarithromycin-based triple therapy and greater use of non-bismuth quadruple (concomitant) therapy in the pharmacist group. Other evaluated items were not significantly different between groups. Conclusions: Clinical pharmacist HP care management was associated with more consistent, guideline-concordant antibiotic regimen selection and higher eradication rates among patients completing confirmatory testing. These findings support a role for pharmacist-led HP care for process improvement including regimen selection and eradication testing; prospective studies with systematic confirmatory testing are needed to determine the model’s effect on eradication itself.

  • Formal Training in Bariatric Endoscopy: Assessing Interest and Need Among United States Gastroenterology Trainees

    by Daniel Staursky, Pooja J. Mude, Viveksandeep Thoguluva Chandrasekar, Zain A. Sobani, John Erikson Yap, Kenneth J. Vega

    Background/aim: Obesity is a significant medical condition with substantial medical and financial burdens. Many patients eligible for metabolic and bariatric surgery (MBS) may never undergo weight loss surgery. Emerging techniques in the bariatric endoscopy (BaE) field, serve to bridge some of these patients meeting criteria for MBS. However, training in BaE is available at only a limited number of bariatric centers nationwide. A survey was conducted among current gastroenterology (GI) trainees to evaluate their existing BaE education, gauge their interest in formal BaE training, and determine the perceived necessity for specialized BaE education. Methods: A 14-question survey was developed and offered in a web-based fashion to GI trainees among various fellowship programs nationally. Survey responses included location of training program, current year of training, BaE interest, and need for BaE training. Results: A total of 122 respondents completed the survey. Males comprised 73% of respondents. General GI fellows were 93% and advanced endoscopy trainees were 7% of respondents. Obesity was seen as a significant issue by 91% of trainees and 80% felt BaE should be included in their didactic education. Only 7% felt they were adequately trained in BaE. Conclusion: Current GI trainees consider obesity an important disease and are interested in learning about BaE during training. Fellow interest exists in pursuing advanced training in BaE but a majority feel their current education is inadequate and are uncomfortable discussing BaE with patients. This demonstrates a need for structured didactics and rotations for trainees regarding endoscopic obesity management.

  • Open Access

    HIV and Non‐HIV Patients Have Similar Rates of Neoplastic Findings on Screening Colonoscopy Within a Predominantly African American Cohort

    by Pooja Mude, Alexandra E. Thomson, Lavannya Atri, Samantha Newman, Carlos Palacio, John Erikson L. Yap, Christian S. Jackson, Kenneth J. Vega

    Introduction: With the reduction in human immunodeficiency virus (HIV)–related mortality secondary to antiretroviral therapy, chronic medical conditions and age‐related cancers account for a larger proportion of mortality among those with HIV. Cancer risk overall remains elevated in HIV patients, and cancer screening data in this population is limited. The primary study aim was to determine whether screening colonoscopy findings differed between HIV and non‐HIV patients.Methods: A retrospective review of adults with/without HIV undergoing screening colonoscopy between February 2015 and September 2022 was performed. HIV patients were matched with non‐HIV patients by sex, race, and age, undergoing screening colonoscopy within six business days of their matched patients. Demographic data included age, race, sex, family history of colorectal cancer (CRC), smoking status, alcohol use, along with endoscopic and histologic findings that were compared between the matched pairs.Results: Ninety matched pairs of HIV and non‐HIV patients undergoing screening colonoscopy comprised the study population. The study group was 78.9% African American, 55.6% male, with a mean age of 59.0 years in HIV patients and 54.9 years in non‐HIV patients. Procedure indication was average risk screening in 91.1% of patients. No statistically significant differences in screening colonoscopy findings or polyp histology were observed between HIV and non‐HIV patients.Discussion: Similar rates of polyps were found at screening colonoscopy regardless of HIV status. CRC screening recommendations are appropriate for the HIV patient population without limitation.


  • Open Access

    Manifestation of Cytomegalovirus‐Associated Gastritis and Colitis With Immunosuppression and Review of Literature

    by Ahmad Mirza, John Erikson Yap, Rajan Kapoor, Imran Gani

    Cytomegalovirus (CMV) infection in immunocompromised patients can cause significant morbidity and mortality. Early recognition and treatment helps to improve outcome. We present a case of postrenal transplant CMV infection causing both upper and lower gastrointestinal infection and symptoms. Patient developed significant co‐morbidity which required multiple hospital admissions and therapeutic interventions.

  • Eosinophilic enteritis in a case of cystic fibrosis: an elusive diagnosis with an elementary cure

    by Gomathy Aarthy Nageswaran, Viveksandeep Thoguluva Chandrasekar, Intisar Ghleilib, John Erikson Yap

    A late adolescent man diagnosed with cystic fibrosis and presenting with predominantly gastrointestinal symptoms, including chronic constipation, exocrine pancreatic insufficiency and gastro-oesophageal reflux disease, experienced recurrent episodes of nausea, vomiting and abdominal pain. CT of the abdomen unveiled the presence of chronic appendicitis, alongside constipation without evidence of distal intestinal obstruction syndrome. Endoscopic biopsies revealed small bowel eosinophilic infiltrates. Subsequently, the patient underwent an appendectomy, and a tailored regimen was established to address constipation, resulting in an initial alleviation of his symptoms. Three months later, a resurgence of symptoms occurred, coinciding with persistent intestinal eosinophilic infiltrates. A diagnosis of eosinophilic enteritis was rendered, and treatment commenced with an oral dosage of 40 mg of prednisone. Two weeks later, the patient experienced symptom resolution, corroborated by the findings of an endoscopic biopsy conducted 8 weeks later. During a follow-up examination 6 months later, the patient remained asymptomatic.

  • Open Access

    Tokyo Guidelines (TG18) for Acute Cholangitis Provide Improved Specificity and Accuracy Compared to Fellow Assessment

    by Amit Hudgi, Anabel L. Cartelle, Amr Ahmed, Ahmad Alkaddour, Carlos Palacio, Kenneth J. Vega, John Erikson L. Yap

    Acute cholangitis results in significant mortality unless treated promptly. The diagnostic grading criteria of the 2018 Tokyo Guidelines (TG18) are used worldwide as the standard for acute cholangitis (AC) management but validation in clinical practice is required. Use of the Tokyo 2018 (TG18) guidelines in improving the diagnostic accuracy and early detection of AC compared to fellow clinical assessment. A retrospective review of patient records from 1/2010-9/2019 seen at Augusta University - Medical College of Georgia with the International Classification of Diseases, Ninth Revision (ICD-9) code “cholangitis” and/or ICD-10 codes “acute cholangitis, other cholangitis, and calculus of bile duct with cholangitis” was performed. Inclusion criteria were gastroenterology inpatient consult fellow evaluation and clinical diagnosis of AC. A definitive diagnosis of AC was determined following endoscopic retrograde cholangiopancreatography (ERCP). TG18 scoring for AC was then performed, categorized as either diagnostic/non-diagnostic, and compared to fellow clinical assessments following definitive diagnosis post-ERCP. Data were analyzed with chi-square testing. Two hundred six patients were identified using ICD codes. Ninety-one met inclusion criteria and were analyzed. The mean patient age of the overall group was 67 years old (standard deviation of 13.3 years) with males comprising 69% and non-Hispanic white 56% of the study group. TG18 criteria assessment had a sensitivity of 86% and specificity of 63% for patients with AC post ERCP (p <0.05). TG18 accuracy was 81%. In comparison, fellow clinical suspicion had a sensitivity of 90.3% and specificity of 0% (NS). Fellow accuracy was 71%. No difference in fellows’ diagnosis of suspected AC was noted based on the training year. Application of the TG18 criteria for AC reduces the false positive rate and improves diagnostic accuracy, thus decreasing costs along with avoiding unnecessary ERCPs with associated complications.


  • Open Access

    Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review

    by Mohammad Azam, Amit Hudgi, Pearl Princess Uy, Jinal Makhija, John Erikson L Yap

    Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review


  • Open Access

    Human Intestinal Spirochetosis: A Rare Case of Intermittent Bloating and Hematochezia

    by Reinaldo L. Pérez Moux, Pooja Mude, Shreyans Doshi, Kiran Madwani, Amanda Barrett, John Erikson L. Yap

    Human intestinal spirochetosis (HIS) is a condition where spirochetes, a group of spiral-shaped bacteria, attach to the apical membrane of the human colorectal epithelium. Although most findings of HIS are simply incidental discoveries found during screening colonoscopies, the ability to mimic the presentation of inflammatory bowel diseases should prompt consideration of this condition as part of a working differential diagnosis. Herein, we present the case of a 57-year-old bisexual, African American male with a medical history of Human Immunodeficiency Virus (HIV) on antiretroviral therapy (ART) with an undetectable viral load that presented for an elective, outpatient colonoscopy after experiencing four months of intermittent bloating and hematochezia. Histologic examination of colonic biopsies confirmed a diagnosis of HIS. The nonspecific clinical presentation in the setting of well-controlled HIV makes HIS a formidable diagnostic challenge that requires increased awareness.


  • Open Access

    Severe Hypertriglyceridemia-Induced Necrotizing Pancreatitis Associated With Ketogenic Diet in a Well-Controlled Patient With Type 2 Diabetes Mellitus

    by Jacqueline T. Chan, Pooja J. Mude, Whitney Canfield, Jinal Makhija, John Erikson L. Yap

    The ketogenic diet (keto diet) has become an increasingly popular approach for both weight loss and as an alternative diet for type 2 diabetes mellitus (T2DM). Owing to the nature of the keto diet, patients are at risk of developing hypertriglyceridemia (HTG) due to the high amount of triglycerides consumed by individuals during the initiation of this diet. Acute pancreatitis can result from HTG. We present a case of a 19-year-old African American male with well-controlled T2DM and no history of HTG who developed severe necrotizing HTG-induced pancreatitis after an unsupervised three-month trial of the keto diet.


  • Open Access

    Iatrogenic biloma: a rare and delayed complication of a life-saving transarterial hepatic embolisation

    by Amit R Hudgi, Haoran Peng, Subbaramia Sridhar, John Erikson Yap